TABLE 2.
Clinical indicator | Beta | HR | 95% CI for HR | P value |
AGE | 0.013074 | 1.01316 | 0.9948–1.0319 | 0.16138 |
B2M | 0.001555 | 1.001556 | 0.9951–1.0080 | 0.636028 |
CRP | –0.002855 | 0.997149 | 0.9895–1.0048 | 0.466398 |
CREAT | 0.15395 | 1.166433 | 1.0626–1.2804 | 0.001208* |
LDH | 0.003973 | 1.003981 | 1.0018–1.0061 | 0.000255* |
ALB | –0.430165 | 0.650402 | 0.4894–0.8644 | 0.003035* |
HGB | –0.005505 | 0.99451 | 0.8929–1.1076 | 0.920218 |
ASPC | 0.000926 | 1.000927 | 0.9911–1.0109 | 0.85443 |
BMPC | 0.001769 | 1.00177 | 0.9922–1.0115 | 0.718921 |
MRI | 0.011171 | 1.011233 | 1.0011–1.0214 | 0.029327* |
Cyto_Abn | 0.525037 | 1.690522 | 1.2046–2.3725 | 0.002393* |
Riskgroup | 0.780364 | 2.182267 | 1.4950–3.1855 | 5.26E-05* |
HR, hazard ratio; CI, confidence interval; *p < 0.05.
Concordance-index = 0.741 (se = 0.021).
Likelihood ratio test = 108.3, p = < 2e-16.
Wald test = 114.5, p = < 2e-16.
Score (logrank) test = 129.4, p = < 2e-16.